Read + Share
Amedeo Smart
Independent Medical Education
Xu N, Yang XF, Xue SL, Tan JW, et al. Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells. Biochem Biophys Res Commun 2022;595:54-61.PMID: 35101664
Email
LinkedIn
Facebook
Twitter
Privacy Policy